Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.
Biocytogen, Radiance partner for bispecific antibody-drug conjugate
Share this article The partnership aims to advance the development of a first-in-class fully human anti-HER2/TROP2 BsADC for cancer treatments. Credit: Spectral-Design/shutterstock.com. Biocytogen Pharmaceuticals and